SJS Investment Consulting’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$73 2556
2025
Q4
$73 Hold
1
﹤0.01% 1985
2025
Q3
$44 Buy
+1
New +$40 ﹤0.01% 1614

Other funds holding RNAM

SJS Investment Consulting's RNAM Position: Q1 2026 in Review

SJS Investment Consulting sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1 share — an estimated $73 sold.

SJS Investment Consulting first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $73 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • SJS Investment Consulting reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • SJS Investment Consulting sold 1 Avidity Biosciences share in Q1 2026, an estimated $73.
  • SJS Investment Consulting first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
  • SJS Investment Consulting's Avidity Biosciences position peaked at $73 in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.